Ask AI
ProCE Banner Activity

Ask Us Europe Study: Checking in on Treatment Optimization

Clinical Thought

Prior studies indicated high levels of interest in long-acting antiretroviral therapy (LA ART), but real-world uptake has been slow. Results of the Ask US Europe study, presented at AIDS 2026, suggested that one reason for this gap may be that healthcare professionals are simply not regularly discussing treatment options with patients. 

Released: August 19, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

International AIDS Society

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

Financial Disclosures

Primary Author

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, MSD, VIIV.